This finding is consistent with a previous study that Parkin-dependent mitophagy usually works in neurodegenerative disease, whereas Bnip3-related mitophagy affects metabolic disorders such as fatty liver disease and diabetes (Li et al., 2018). Here, PRKN is linked to fatty liver disease.